ClinicalTrials.gov
ClinicalTrials.gov Menu

Assessing Outcome After H-graft Shunt Placement (PHTN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00519610
Recruitment Status : Completed
First Posted : August 22, 2007
Last Update Posted : August 15, 2012
Sponsor:
Information provided by (Responsible Party):
Kenneth Luberice, University of South Florida

Brief Summary:
The objective of this study is to evaluate the pre-operative symptoms and medical history of patients with portal hypertension who have undergone placement of H-graft portacaval shunts and correlate this with patient outcomes.

Condition or disease Intervention/treatment
Portal Hypertension Other: Chart Review

Detailed Description:
Research data will be collected by accessing the Tampa General Hospital medical record charts as well as the Harbourside medical charts, and extracting the necessary research data. The charts will be reviewed for the relevant medical information in order to assess outcomes in patients having H-graft shunts placed for the treatment of portal hypertension.

Study Type : Observational
Actual Enrollment : 66 participants
Official Title: A Study Assessing Patient Outcomes After Placement of H-graft Portacaval Shunts for the Treatment of Portal Hypertension
Study Start Date : July 2007
Actual Study Completion Date : July 2010

Group/Cohort Intervention/treatment
I
Patients will have charts reviewed for relevant medical information before and after surgery to assess patient outcome after placement of H-graft shunt for the treatment of portal hypertension.
Other: Chart Review
Patients' charts will be reviewed for relevant medical information.



Primary Outcome Measures :
  1. The objective of this study is to evaluate the pre-operative symptoms and medical history of patients with portal hypertension who have undergone placement of H-graft portacaval shunts and correlate this with patient outcomes. [ Time Frame: 5 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients with portal hypertension
Criteria

Inclusion Criteria:

  • Patients who have had H-graft shunts placed for the treatment of portal hypertension.

Exclusion Criteria:

  • Patients under the age of 18 will not be included in this study.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00519610


Locations
United States, Florida
Tampa General Hospital/University of South Florida
Tampa, Florida, United States, 33606
Sponsors and Collaborators
University of South Florida
Investigators
Principal Investigator: Alexander S Rosemurgy, MD University of South Florida

Responsible Party: Kenneth Luberice, Clinical Research Coordinator, University of South Florida
ClinicalTrials.gov Identifier: NCT00519610     History of Changes
Other Study ID Numbers: 105982
First Posted: August 22, 2007    Key Record Dates
Last Update Posted: August 15, 2012
Last Verified: August 2012

Keywords provided by Kenneth Luberice, University of South Florida:
portal hypertension, H-graft shunt

Additional relevant MeSH terms:
Hypertension
Hypertension, Portal
Vascular Diseases
Cardiovascular Diseases
Liver Diseases
Digestive System Diseases